Naomi Fei, Sijin Wen, Rajesh Ramanathan, Melissa E. Hogg, Amer H. Zureikat, Michael T. Lotze, . . . Brian A. Boone. (2021). SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma. Wiley.
Chicago Style (17th ed.) CitationNaomi Fei, et al. SMAD4 Loss Is Associated with Response to Neoadjuvant Chemotherapy Plus Hydroxychloroquine in Patients with Pancreatic Adenocarcinoma. Wiley, 2021.
MLA (9th ed.) CitationNaomi Fei, et al. SMAD4 Loss Is Associated with Response to Neoadjuvant Chemotherapy Plus Hydroxychloroquine in Patients with Pancreatic Adenocarcinoma. Wiley, 2021.
Warning: These citations may not always be 100% accurate.